Science Explorer Back to mapMap
Discussion
Topic · Surgery

Pancreatitis Pathology and Treatment

Pancreatitis Pathology and Treatment is a research topic within Surgery. Science Explorer counts 51k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and management of pancreatitis, covering topics such as acute and chronic pancreatitis, pancreatic disease burden, endoscopic drainage techniques, severity assessment, genetic factors, inflammatory mediators, organ failure, nutritional support, and epidemiology.

  • Acute Pancreatitis
  • Chronic Pancreatitis
  • Pancreatic Disease
  • Endoscopic Drainage
  • Severity Assessment
  • Genetic Factors
  • Inflammatory Mediators
  • Organ Failure
  • Nutritional Support
  • Epidemiology
Research works
51k
fractional, since 1950
In the world top 10%
5.1k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+6%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now
Pancreatitis Pathology and Treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Pancreatitis Pathology and Treatment research?

By volume, the United States and China publish the most (1.9k and 1.8k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.9k works
  2. 2 China 1.8k works
  3. 3 India 749 works
  4. 4 Japan 681 works
  5. 5 United Kingdom 333 works
  6. 6 Germany 307 works
  7. 7 Italy 305 works
  8. 8 Spain 299 works
  9. 9 Türkiye 254 works
  10. 10 South Korea 210 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.0%China: 26.4%India: 10.9%Japan: 9.9%6 others listed: 24.8%28%largest
United States1,929 · 28.0%China1,817 · 26.4%India749 · 10.9%Japan681 · 9.9%6 others listed1,708 · 24.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Pancreatitis Pathology and Treatment research?

By volume in 2022-now, Sichuan University publishes the most Pancreatitis Pathology and Treatment research, followed by Mayo Clinic and Harvard University.

By volume, 2022-now

  1. 1 Sichuan UniversityChina 76 works
  2. 2 Mayo ClinicUnited States 66 works
  3. 3 Harvard UniversityUnited States 60 works
  4. 4 Shanghai Jiao Tong UniversityChina 59 works
  5. 5 All India Institute of Medical SciencesIndia 59 works
  6. 6 Nanjing Medical UniversityChina 46 works
  7. 7 Post Graduate Institute of Medical Education and ResearchIndia 45 works
  8. 8 Capital Medical UniversityChina 44 works
  9. 9 Semmelweis UniversityHungary 41 works
  10. 10 Zhejiang UniversityChina 41 works

Who are the leading researchers in Pancreatitis Pathology and Treatment?

The most-cited researchers publishing on Pancreatitis Pathology and Treatment include Douglas G. Altman, Ahmedin Jemal and Walter Churchill Willett.

  1. 1 Douglas G. Altman United Kingdom 862k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Walter Churchill Willett United States 411k citations
  4. 4 Guido Kroemer France 386k citations
  5. 5 Bert Vogelstein United States 373k citations
  6. 6 John J.V. McMurray United Kingdom 349k citations
  7. 7 Hermann Brenner Germany 343k citations
  8. 8 Shizuo Akira Japan 342k citations
  9. 9 Jun Wang China 340k citations
  10. 10 Giuseppe Remuzzi Italy 328k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Pancreatitis Pathology and Treatment?

The most cited paper in Pancreatitis Pathology and Treatment is "Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus" (Peter A. Banks, Thomas L. Bollen, Christos Dervenis et al., 2012), with 7,229 citations. Next come "Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine" (6,826) and "The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After" (4,323).

Most cited papers
#PaperReleasedCitations
1 Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus Peter A. Banks, Thomas L. Bollen, Christos Dervenis et al. · Gut Open access 25 Oct 2012 7,229
2 Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine Daniel D. Von Hoff et al. · New England Journal of Medicine Open access 16 Oct 2013 6,826
3 The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After Claudio Bassi et al. · Surgery Open access 28 Dec 2016 4,323
4 Postoperative pancreatic fistula: An international study group (ISGPF) definition Claudio Bassi, Christos Dervenis, Giovanni Butturini et al. · Surgery Jul 2005 4,297
5 Genomic analyses identify molecular subtypes of pancreatic cancer Peter J. Bailey et al. · Nature 103 authors 23 Feb 2016 3,805
All 99 most cited papers, with filters and sorting

Where is Pancreatitis Pathology and Treatment research done?

The largest centres of Pancreatitis Pathology and Treatment research in 2022-now are Beijing (China), Shanghai (China), Tokyo (Japan) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Verona.

Largest cities, 2022-now

  1. 1 BeijingChina 197 works
  2. 2 ShanghaiChina 177 works
  3. 3 TokyoJapan 140 works
  4. 4 SeoulSouth Korea 111 works
  5. 5 ChengduChina 109 works
  6. 6 NanjingChina 88 works
  7. 7 MoscowRussia 82 works
  8. 8 GuangzhouChina 81 works
  9. 9 IstanbulTürkiye 79 works
  10. 10 HangzhouChina 76 works

Where it is the local speciality

  1. VeronaIT · 28.1 works11×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Pancreatitis Pathology and Treatment than the world average.

See Pancreatitis Pathology and Treatment on the map

Where is the best place to study Pancreatitis Pathology and Treatment?

Among universities, judged by research, Sichuan University, Harvard University and Johns Hopkins University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 21.77%fractional works in this field (log) →share of work in the world top 10% →Sichuan UniversityJohns Hopkins Univer…Nanchang UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sichuan UniversityChina 72.020.7%3.9×76 +60.7%
2Harvard UniversityUnited States 65.416.5%2.1×60 -21.9%
3Johns Hopkins UniversityUnited States 63.819.6%2.3×30 -10.1%
4Nanchang UniversityChina 63.618.2%5.1×34 +22.9%
5Wenzhou Medical UniversityChina 63.625.2%6.4×28 +3.8%
6Lanzhou UniversityChina 63.029.7%3.2×19 +253.3%
7Capital Medical UniversityChina 61.917.2%4.7×44 +34.8%
8Shanghai Jiao Tong UniversityChina 61.519.9%2.4×59 -4.7%
9University of AmsterdamNetherlands 60.928.3%2.3×12 -7.1%
10Dalian Medical UniversityChina 60.822.4%9.8×17 +68.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Pancreatitis Pathology and Treatment, country by country

Is Pancreatitis Pathology and Treatment research growing?

Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Pancreatitis Pathology and Treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pancreatitis Pathology and Treatment as a percentage of every work published that year, 0.041% in 2024.

still counting0.025%0.050%0.075%Pancreatitis Pathology and Treatment0.039% in 202519801990200020102020

Fractional works of Pancreatitis Pathology and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Pancreatitis Pathology and Treatment10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Pancreatitis Pathology and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.